NCT00146250 is a Phase 4 clinical trial of Nitrous oxide in Anesthesia, sponsored by Austin Health.

Who is sponsoring NCT00146250?

NCT00146250 is sponsored by Austin Health.

What drugs are being tested in NCT00146250?

Interventions in NCT00146250: Nitrous oxide.

What condition does NCT00146250 study?

NCT00146250 studies Anesthesia.

Is NCT00146250 still recruiting?

NCT00146250 is currently completed. Last updated 11 January 2018.

Last reviewed 2018-01-11 · How we verify

NCT00146250

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of N2O Administration on Arterial Oxygenation

Completed Phase 4 Last updated 11 January 2018

What this trial tests

Phase 4 trial testing Nitrous oxide in Anesthesia in 20 participants. Completed in 30 September 2005.

Timeline

1 March 2005

Primary endpoint
20 July 2005

30 September 2005

Quick facts

Lead sponsor	Austin Health
Phase	Phase 4
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	20
Start date	1 March 2005
Primary completion	20 July 2005
Estimated completion	30 September 2005

Drugs / interventions tested

Nitrous oxide (NITROUS OXIDE) — full drug profile →

Conditions studied

Anesthesia — all drugs for Anesthesia →

Sponsor

Austin Health — full company profile →

Who can join

18 and older, any sex, with Anesthesia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nitrous oxide is a standard part of most anaesthetic breathing mixtures. It has often been assumed that it reduces the amount of oxygen reaching the lower parts of the lung. However the results of previous studies and of some computer modelling suggests the opposite may be true, and that oxygen levels in the blood are actually higher with nitrous oxide. This study seeks to determine whether nitrous oxide increases or decreases blood oxygen levels in anaesthetized patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Nitrous oxide

Trials testing the same drug.

NCT06498908 — Intracervical Balloon Placement With Nitrous Oxide Administration · Phase 3 · withdrawn
NCT06702631 — Nitrous Oxide Neuroimaging · EARLY_PHASE1 · recruiting
NCT05383495 — Anxiolysis for Laceration Repair in Children · Phase 3 · recruiting
NCT05895383 — Self-Adjusted Nitrous Oxide: A Feasibility Study in the Setting of Vasectomy · Phase 4 · recruiting
NCT05388942 — Virtual Reality Hypnosis Versus Inhaled Nitrous Oxide in Anterior Shoulder Dislocation Reduction: an Open Multicenter Ra · NA · unknown

Other recruiting trials for Anesthesia

Currently open trials in the same condition.

NCT07294092 — Ketamine and Propofol NeuroImaging · EARLY_PHASE1 · recruiting
NCT07290205 — Remimazolam NeuroImaging · EARLY_PHASE1 · recruiting
NCT07465185 — Intrathecal Bupivacaine With or Without Dexmetomidine for Cesserian Delivery · Phase 2 · recruiting
NCT07269808 — Sedation During Endoscopy Using Remimazolam: Efficacy in a Novel Exploration · Phase 3 · recruiting
NCT07443254 — Prospective IR-led Sedation Feasibility · Phase 1, PHASE2 · recruiting

Other Austin Health trials

Trials by the same sponsor.

NCT07535580 — Patient-Reported Stent Symptom Outcomes and Migration Rates Following Modified Single-J Ureteric Stent Insertion After U · NA · completed
NCT06916819 — Food Challenge at Home or in Medical Practice - the FoodCHOMP Study · NA · recruiting
NCT04454229 — The Use of Penicillin Allergy Clinical Decision Rule to Enable Direct Oral Penicillin Challenge · NA · completed
NCT04344964 — Endoscopy-related Phone Consultation During the COVID-19 Outbreak · completed
NCT03610061 — A Trial of Radiotherapy and Durvalumab in DLBCL and FL · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00146250 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Austin Health
Last refreshed: 11 January 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00146250.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing